High serum resistin level may be an indicator of the severity of coronary disease in acute coronary syndrome

Chinese Medical Sciences Journal

Volumn 24, Issue 3, 2009, Pages 161-166

  Wang, Hao ^a   Chen, De You ^a   Cao, Jian ^a   He, Zuo Yun ^b   Zhu, Bing Po ^a   Long, Min ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Acute coronary syndrome; Atherosclerosis; Resistin; Stable angina pectoris

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; RESISTIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; DYSLIPIDEMIA; ELECTROCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE TEST; FEMALE; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SERUM; STABLE ANGINA PECTORIS;

EID: 70350340829     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1001-9294(09)60082-1     Document Type: Article

References (24)

1. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature 2001; 409:307-312 (Pubitemid 32151228)
2. Qi Y, Nie Z, Lee YS, et al. Loss of resistin improves glucose homeostasis in leptin deficiency. Diabetes 2006; 55:3083-3090 (Pubitemid 44923646)
3. Tomimoto S, Ojika T, Shintani N, et al. Markedly reduced white adipose tissue and increased insulin sensitivity in adcyapl-deficient mice. J Pharmacol Sci 2008; 107:41-48 (Pubitemid 351760826)
4. Rubin DA, McMurray RG, Harrell JS, et al. The association between insulin resistance and cytokines in adolescents: the role of weight status and exercise. Metabolism 2008; 57:683-690
5. Fruhbeck G, Salvador J. Role of adipocytokines in metabolism and disease. Nutrition Research 2004; 4:803-826
6. Kasera S, Kaserb A, Sandhofera A, et al. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 2003; 309:286-290
7. Kawanamia D, Maemura K, Takedaa N, et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun 2004; 314:415-419 (Pubitemid 38084733)
8. Burnett MS, Leea CW, Kinnairda TD, et al. The potential role of resistin in atherosclerosis. Atherosclerosis 2005; 18:241-248
9. Jung HS, Park KH, Cho YM, et al. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc Res 2006; 69:76-85.
10. NHLBI Obesity Education Initiative. Clinical Guideline on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults: the Evidence Report. Bethesda, MD: National Institute of Health; 1998.
11. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 289:76-79 (Pubitemid 32893993)
12. Lakkaa HM, Lakkaa TA, Tuomilehtod J, et al. Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J 2002; 23:706-713
13. Sato N, Kobayashi K, Inoguchi T, et al. Adenovirus-mediated high expression of resistin causes dyslipidemia in mice. Endocrinology 2005; 146:2. (Pubitemid 40051749)
14. Reilly MP, Lehrke M, Wolfe ML, et al. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005; 111:932-939 (Pubitemid 40279897)
15. Ohmori R, Momiyama Y, Kato R, et al. Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J Am Coll Cardiol 2005; 46:379-380 (Pubitemid 40966873)
16. Lubos E, Messow CM, Schnabel R, et al. Resistin, acute coronary syndrome and prognosis results from the AtheroGene study. Atherosclerosis 2007; 193:121-128 (Pubitemid 46783904)
17. Chu SY, Ding WH, Li K, et al. Plasma resistin associated with myocardium injury in patients with acute coroanry syndrome. Cir J 2008;72:1449-2253
18. Diez JJ, Iglesias P, Fernandez-Reyes MJ, et al. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease. Clin Endocrinol (Oxf) 2005; 62: 242-249 (Pubitemid 40203922)
19. Burnett MS, Devaney JM, Adenika RJ, et al. Cross-sectional associations of resistin, coronary heart disease, and insulin resistance. J Clin Endocrinol Metab 2006; 91:64-68
20. Barb D, Wadhwa SG, Kratzsch J, et al. Circulating resistin levels are not associated with fat redistribution, insulin resistance, or metabolic profile in patients with the highly active antiretroviral therapy-induced metabolic syndrome. J Clin Endocrinol Metab 2005; 90:5324-5328 (Pubitemid 41262295)
21. Lehrke M, Reilly MP, Millington SC, et al. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 2004; 1:161-168 (Pubitemid 40412718)
22. Furman MI, Barnard MR, Krueger LA, et al. Circulating monocyte-platelet aggregates are an early marker of acute myocardial injury. J Am Coll Cardiol 2001; 39:1002-1006
23. Mu H, Ohashi R, Yan S, et al. Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc Res 2006; 70:146-157
24. Rae C, Graham A. Human resistin promotes macrophage lipid accumulation. Diabetologia 2006; 49:1112-1114